M Huggins, M Bloch, S Wiggins, S Adam, O Suchowersky, M Trew, M Klimek, C R Greenberg, M Eleff, L P Thompson. Am J Med Genet 1992
Times Cited: 181
Times Cited: 181
Times Cited
Times Co-cited
Similarity
The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing.
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
S Wiggins, P Whyte, M Huggins, S Adam, J Theilmann, M Bloch, S B Sheps, M T Schechter, M R Hayden. N Engl J Med 1992
45
Predictive testing for Huntington disease in Canada: the experience of those receiving an increased risk.
M Bloch, S Adam, S Wiggins, M Huggins, M R Hayden. Am J Med Genet 1992
M Bloch, S Adam, S Wiggins, M Huggins, M R Hayden. Am J Med Genet 1992
39
Psychological costs and benefits of predictive testing for Huntington's disease.
A M Codori, J Brandt. Am J Med Genet 1994
A M Codori, J Brandt. Am J Med Genet 1994
33
A worldwide assessment of the frequency of suicide, suicide attempts, or psychiatric hospitalization after predictive testing for Huntington disease.
E W Almqvist, M Bloch, R Brinkman, D Craufurd, M R Hayden. Am J Hum Genet 1999
E W Almqvist, M Bloch, R Brinkman, D Craufurd, M R Hayden. Am J Hum Genet 1999
31
Three-year follow-up after presymptomatic testing for Huntington's disease in tested individuals and partners.
A Tibben, R Timman, E C Bannink, H J Duivenvoorden. Health Psychol 1997
A Tibben, R Timman, E C Bannink, H J Duivenvoorden. Health Psychol 1997
30
Prediction of psychological functioning one year after the predictive test for Huntington's disease and impact of the test result on reproductive decision making.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. J Med Genet 1996
26
25
Predictors of psychological adjustment to genetic testing for Huntington's disease.
A M Codori, P R Slavney, C Young, D L Miglioretti, J Brandt. Health Psychol 1997
A M Codori, P R Slavney, C Young, D L Miglioretti, J Brandt. Health Psychol 1997
39
Presymptomatic DNA testing for Huntington disease: identifying the need for psychological intervention.
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
A Tibben, H J Duivenvoorden, M Vegter-van der Vlis, M F Niermeijer, P G Frets, J J van de Kamp, R A Roos, H G Rooijmans, F Verhage. Am J Med Genet 1993
32
Self-selection in predictive testing for Huntington's disease.
A M Codori, R Hanson, J Brandt. Am J Med Genet 1994
A M Codori, R Hanson, J Brandt. Am J Med Genet 1994
23
On attitudes and appreciation 6 months after predictive DNA testing for Huntington disease in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegtervan der Vlis, R A Roos, H G Rooymans, G J van Ommen, F Verhage. Am J Med Genet 1993
23
A polymorphic DNA marker genetically linked to Huntington's disease.
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
J F Gusella, N S Wexler, P M Conneally, S L Naylor, M A Anderson, R E Tanzi, P C Watkins, K Ottina, M R Wallace, A Y Sakaguchi. Nature 1983
21
Adverse psychological events occurring in the first year after predictive testing for Huntington's disease. The Canadian Collaborative Study Predictive Testing.
K Lawson, S Wiggins, T Green, S Adam, M Bloch, M R Hayden. J Med Genet 1996
K Lawson, S Wiggins, T Green, S Adam, M Bloch, M R Hayden. J Med Genet 1996
30
Exploration of the effects of predictive testing for Huntington disease on intimate relationships.
K A Quaid, M K Wesson. Am J Med Genet 1995
K A Quaid, M K Wesson. Am J Med Genet 1995
25
Attitudes of persons at risk for Huntington disease toward predictive testing.
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
S Kessler, T Field, L Worth, H Mosbarger. Am J Med Genet 1987
18
29
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
18
Predictive testing for Huntington disease: nonparticipants compared with participants in the Dutch program.
I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
I M van der Steenstraten, A Tibben, R A Roos, J J van de Kamp, M F Niermeijer. Am J Hum Genet 1994
17
Impact of genetic testing for Huntington disease on the family system.
S K Sobel, D B Cowan. Am J Med Genet 2000
S K Sobel, D B Cowan. Am J Med Genet 2000
17
Predictive testing for Huntington's disease: risk perception, reasons for testing and psychological profile of test applicants.
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
M Decruyenaere, G Evers-Kiebooms, A Boogaerts, J J Cassiman, T Cloostermans, K Demyttenaere, R Dom, J P Fryns, H Van den Berghe. Genet Couns 1995
23
Presymptomatic diagnosis of delayed-onset disease with linked DNA markers. The experience in Huntington's disease.
J Brandt, K A Quaid, S E Folstein, P Garber, N E Maestri, M H Abbott, P R Slavney, M L Franz, L Kasch, H H Kazazian. JAMA 1989
J Brandt, K A Quaid, S E Folstein, P Garber, N E Maestri, M H Abbott, P R Slavney, M L Franz, L Kasch, H H Kazazian. JAMA 1989
16
Reactions to predictive testing in Huntington disease: case reports of coping with a new genetic status.
T B Wahlin, A Lundin, L Bäckman, E Almqvist, A Haegermark, B Winblad, M Anvret. Am J Med Genet 1997
T B Wahlin, A Lundin, L Bäckman, E Almqvist, A Haegermark, B Winblad, M Anvret. Am J Med Genet 1997
66
Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
16
Predictive testing for Huntington disease: II. Demographic characteristics, life-style patterns, attitudes, and psychosocial assessments of the first fifty-one test candidates.
M Bloch, M Fahy, S Fox, M R Hayden. Am J Med Genet 1989
M Bloch, M Fahy, S Fox, M R Hayden. Am J Med Genet 1989
16
Uptake of presymptomatic predictive testing for Huntington's disease.
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
D Craufurd, A Dodge, L Kerzin-Storrar, R Harris. Lancet 1989
16
Psychological consequences and predictors of adverse events in the first 5 years after predictive testing for Huntington's disease.
E W Almqvist, R R Brinkman, S Wiggins, M R Hayden. Clin Genet 2003
E W Almqvist, R R Brinkman, S Wiggins, M R Hayden. Clin Genet 2003
18
Psychological distress in applicants for predictive DNA testing for autosomal dominant, heritable, late onset disorders. The Rotterdam/Leiden Genetics Workgroup.
A C DudokdeWit, A Tibben, H J Duivenvoorden, P G Frets, M W Zoeteweij, M Losekoot, A van Haeringen, M F Niermeijer, J Passchier. J Med Genet 1997
A C DudokdeWit, A Tibben, H J Duivenvoorden, P G Frets, M W Zoeteweij, M Losekoot, A van Haeringen, M F Niermeijer, J Passchier. J Med Genet 1997
25
Distress in individuals facing predictive DNA testing for autosomal dominant late-onset disorders: comparing questionnaire results with in-depth interviews. Rotterdam/Leiden Genetics Workgroup.
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier, R W Trijsburg. Am J Med Genet 1998
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier, R W Trijsburg. Am J Med Genet 1998
22
Psychological effects of presymptomatic DNA testing for Huntington's disease in the Dutch program.
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
A Tibben, H J Duivenvoorden, M F Niermeijer, M Vegter-van der Vlis, R A Roos, F Verhage. Psychosom Med 1994
23
Psychological impact of genetic testing for Huntington's disease: an update of the literature.
B Meiser, S Dunn. J Neurol Neurosurg Psychiatry 2000
B Meiser, S Dunn. J Neurol Neurosurg Psychiatry 2000
14
Psychological consequences of predictive genetic testing: a systematic review.
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
M Broadstock, S Michie, T Marteau. Eur J Hum Genet 2000
14
DNA-testing for Huntington's disease in The Netherlands: a retrospective study on psychosocial effects.
A Tibben, M Vegter-van der Vlis, M I Skraastad, P G Frets, J J van der Kamp, M F Niermeijer, G J van Ommen, R A Roos, H G Rooijmans, D Stronks. Am J Med Genet 1992
A Tibben, M Vegter-van der Vlis, M I Skraastad, P G Frets, J J van der Kamp, M F Niermeijer, G J van Ommen, R A Roos, H G Rooijmans, D Stronks. Am J Med Genet 1992
17
13
Adverse effects of predictive testing for Huntington disease underestimated: long-term effects 7-10 years after the test.
Reinier Timman, Raymund Roos, Anneke Maat-Kievit, Aad Tibben. Health Psychol 2004
Reinier Timman, Raymund Roos, Anneke Maat-Kievit, Aad Tibben. Health Psychol 2004
17
An inventory for measuring depression.
A T BECK, C H WARD, M MENDELSON, J MOCK, J ERBAUGH. Arch Gen Psychiatry 1961
A T BECK, C H WARD, M MENDELSON, J MOCK, J ERBAUGH. Arch Gen Psychiatry 1961
12
Suicide and attempted suicide in Huntington disease: implications for preclinical testing of persons at risk.
L A Farrer. Am J Med Genet 1986
L A Farrer. Am J Med Genet 1986
11
Predictive testing for Huntington disease: I. Description of a pilot project in British Columbia.
S Fox, M Bloch, M Fahy, M R Hayden. Am J Med Genet 1989
S Fox, M Bloch, M Fahy, M R Hayden. Am J Med Genet 1989
11
Attitudes toward presymptomatic testing in Huntington disease.
C Mastromauro, R H Myers, B Berkman. Am J Med Genet 1987
C Mastromauro, R H Myers, B Berkman. Am J Med Genet 1987
11
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
11
Presymptomatic DNA-testing for Huntington disease: pretest attitudes and expectations of applicants and their partners in the Dutch program.
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
A Tibben, P G Frets, J J van de Kamp, M F Niermeijer, M Vegter-van der Vlis, R A Roos, G J van Ommen, H J Duivenvoorden, F Verhage. Am J Med Genet 1993
13
Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
11
Reluctance to undergo predictive testing: the case of Huntington disease.
K A Quaid, M Morris. Am J Med Genet 1993
K A Quaid, M Morris. Am J Med Genet 1993
11
Ten years of presymptomatic testing for Huntington's disease: the experience of the UK Huntington's Disease Prediction Consortium.
P S Harper, C Lim, D Craufurd. J Med Genet 2000
P S Harper, C Lim, D Craufurd. J Med Genet 2000
11
Psychological distress in the 5-year period after predictive testing for Huntington's disease.
Marleen Decruyenaere, Gerry Evers-Kiebooms, Trees Cloostermans, Andrea Boogaerts, Koen Demyttenaere, René Dom, Jean Pierre Fryns. Eur J Hum Genet 2003
Marleen Decruyenaere, Gerry Evers-Kiebooms, Trees Cloostermans, Andrea Boogaerts, Koen Demyttenaere, René Dom, Jean Pierre Fryns. Eur J Hum Genet 2003
13
Predictive testing for Huntington's disease with use of a linked DNA marker.
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
G J Meissen, R H Myers, C A Mastromauro, W J Koroshetz, K W Klinger, L A Farrer, P A Watkins, J F Gusella, E D Bird, J B Martin. N Engl J Med 1988
10
40
Attitudes toward direct predictive testing for the Huntington disease gene. Relevance for other adult-onset disorders. The Canadian Collaborative Group on Predictive Testing for Huntington Disease.
R Babul, S Adam, B Kremer, S Dufrasne, S Wiggins, M Huggins, J Theilmann, M Bloch, M R Hayden. JAMA 1993
R Babul, S Adam, B Kremer, S Dufrasne, S Wiggins, M Huggins, J Theilmann, M Bloch, M R Hayden. JAMA 1993
16
Predictive testing for Huntington's disease: a challenge for persons at risk and for professionals.
G Evers-Kiebooms, M Decruyenaere. Patient Educ Couns 1998
G Evers-Kiebooms, M Decruyenaere. Patient Educ Couns 1998
13
Predicting adaptation to presymptomatic DNA testing for late onset disorders: who will experience distress? Rotterdam Leiden Genetics Workgroup.
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier. J Med Genet 1998
A C DudokdeWit, A Tibben, H J Duivenvoorden, M F Niermeijer, J Passchier. J Med Genet 1998
13
Ethical issues policy statement on Huntington's disease molecular genetics predictive test. International Huntington Association. World Federation of Neurology.
L Went. J Med Genet 1990
L Went. J Med Genet 1990
10
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.